Cencora, Inc.
COR Healthcare Medical Distribution
Cencora, Inc.’s revenue for fiscal 2026 (year ended September 2026) was $337.4 billion, up 5.00% from fiscal 2025.
- Revenue
- +5.52%
- EPS
- +258.4%
- Free cash flow
- −7.81%
- Total debt
- +47.1%
Quarter to September 2026, against a year earlier
Follow COR
Alert me
Cencora, Inc. (COR) Shares outstanding
Cencora, Inc.'s shares outstanding at the end of fiscal 2026 was $194.1M, unchanged from fiscal 2025. Over the past ten years it has ranged from $194.1M (fiscal 2026) to $226.0M (fiscal 2016) — the current reading is the lowest in ten years. Cencora, Inc. ranks 2nd of 11 Medical Distribution companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2026 | $194.1M | (0.58%) |
| FY2025 | $195.2M | (2.53%) |
| FY2024 | $200.3M | (2.11%) |
| FY2023 | $204.6M | (3.13%) |
| FY2022 | $211.2M | 1.32% |
| FY2021 | $208.5M | 1.80% |
| FY2020 | $204.8M | (3.33%) |
| FY2019 | $211.8M | (3.86%) |
| FY2018 | $220.3M | (0.57%) |
| FY2017 | $221.6M | (1.93%) |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Sep 2026 | $191.7M | (1.14%) |
| Jun 2026 | $193.9M | (0.74%) |
| Mar 2026 | $195.4M | 0.03% |
| Dec 2025 | $195.3M | 0.05% |
| 43 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| CAH Cardinal Health, Inc. compare | $233.0M |
| COR Cencora, Inc. | $191.7M |
| MCK McKesson Corporation compare | $116.7M |
| HSIC Henry Schein, Inc. compare | $112.5M |
| ACH Accendra Health, Inc. compare | $76.7M |
| COSM Cosmos Health Inc. compare | $59.9M |
| FOCL FocalTherics compare | $37.5M |
| AHG Akso Health Group Sponsored ADR compare | $16.3M |
| YI 111, Inc. Sponsored ADR compare | $8.8M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on COR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Beneish M-score
- The full statement